Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

It's a plot device beloved by science fiction: our entire universe might be a simulation running on some advanced ...

Abstract: In adversarial environments, unmanned aerial vehicle (UAV) swarms often face challenges such as node failures, battle damage, and strong electromagnetic interference, which may result in ...

Abstract: Distributed adaptive filtering has emerged as a critical methodology across diverse application domains, including wireless sensor networks, distributed signal processing, and intelligent ...

Albom's new novel, Twice, asks a question most of us have daydreamed about: what if you could go back and relive any moment of your life? In the book, a man is born with that exact power, but every ...

Meta announced on Tuesday a new Facebook algorithm update that will showcase more Reels videos tailored to users’ preferences. The update includes features that offer users greater control over the ...

In the latest close session, Recursion Pharmaceuticals (RXRX) was down 5.42% at $5.23. The stock fell short of the S&P 500, which registered a loss of 0.38% for the day. Meanwhile, the Dow experienced ...